Pfizer and biontech receive first authorization in european union for covid-19 vaccine in adolescents

New york and mainz, germany, may 28, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the conditional marketing authorization (cma) for comirnaty® in the european union (eu) has been expanded to include individuals 12 to 15 years of age. this follows the european medicines agency's (ema) committee for medicinal products for human use (chmp) positive opinion to authorize the vaccine in this age group. the extended indication for the cma for comirnaty® is valid in all 27 eu member states.
BNTX Ratings Summary
BNTX Quant Ranking